Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR).
Flatt B, Martin R, Wang TL, Mahaney P, Murphy B, Gu XH, Foster P, Li J, Pircher P, Petrowski M, Schulman I, Westin S, Wrobel J, Yan G, Bischoff E, Daige C, Mohan R.
Flatt B, et al. Among authors: petrowski m.
J Med Chem. 2009 Feb 26;52(4):904-7. doi: 10.1021/jm8014124.
J Med Chem. 2009.
PMID: 19159286